- Home
- MDAI vs PASG Comparison
MDAI vs PASG Comparison
Compare MDAI & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDAI
- PASG
- Stock Information
- Founded
- MDAI 2013
- PASG 2017
- Country
- MDAI United States
- PASG United States
- Employees
- MDAI N/A
- PASG N/A
- Industry
- MDAI Medical/Dental Instruments
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- MDAI Health Care
- PASG Health Care
- Exchange
- MDAI Nasdaq
- PASG Nasdaq
- Market Cap
- MDAI 27.8M
- PASG 31.1M
- IPO Year
- MDAI N/A
- PASG 2020
- Fundamental
- Price
- MDAI $1.23
- PASG $0.36
- Analyst Decision
- MDAI Strong Buy
- PASG Strong Buy
- Analyst Count
- MDAI 2
- PASG 3
- Target Price
- MDAI $4.75
- PASG $7.67
- AVG Volume (30 Days)
- MDAI 421.8K
- PASG 160.6K
- Earning Date
- MDAI 05-06-2025
- PASG 05-13-2025
- Dividend Yield
- MDAI N/A
- PASG N/A
- EPS Growth
- MDAI N/A
- PASG N/A
- EPS
- MDAI N/A
- PASG N/A
- Revenue
- MDAI $29,581,000.00
- PASG N/A
- Revenue This Year
- MDAI N/A
- PASG N/A
- Revenue Next Year
- MDAI $49.47
- PASG N/A
- P/E Ratio
- MDAI N/A
- PASG N/A
- Revenue Growth
- MDAI 63.83
- PASG N/A
- 52 Week Low
- MDAI $0.82
- PASG $0.33
- 52 Week High
- MDAI $3.25
- PASG $1.64
- Technical
- Relative Strength Index (RSI)
- MDAI 37.49
- PASG 34.96
- Support Level
- MDAI $1.04
- PASG $0.33
- Resistance Level
- MDAI $1.31
- PASG $0.54
- Average True Range (ATR)
- MDAI 0.15
- PASG 0.05
- MACD
- MDAI -0.01
- PASG -0.00
- Stochastic Oscillator
- MDAI 24.05
- PASG 14.20
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.